Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael E D Allison

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Hospital Medicine (London, England : 1998)|November 5, 2004
Fatty liverMichael E D Allison
BMJ (Clinical Research Ed.)|July 4, 2008
Fatal reactivation of hepatitis B after chemotherapy for lymphomaRichard Dillon, Gideon M Hirschfield, Michael E D Allison, et al.
Histopathology|January 31, 2016
Any value in a specialist review of liver biopsies? Conclusions of a 4-year reviewAnna L Paterson, Michael E D Allison, Rebecca Brais, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|May 22, 2025
Motivation, self-efficacy, and identity-double-edged swords for relapse prevention in patients with alcohol related cirrhosisChristopher Oldroyd, Tamar Avades, Graham P Martin, et al.
Addiction (Abingdon, England)|November 10, 2025
Zero tolerance for 0%? How should clinicians and other practitioners respond to the use of alcohol-free and low-alcohol products in higher risk groupsJohn Holmes, Christopher K Oldroyd, Colin Drummond, et al.
Cell Death and Differentiation|April 2, 2020
OTULIN protects the liver against cell death, inflammation, fibrosis, and cancerRune Busk Damgaard, Helen E Jolin, Michael E D Allison, et al.
Transplantation|February 27, 2024
Bile Chemistry During Ex Situ Normothermic Liver Perfusion Does Not Always Predict CholangiopathyChristopher J E Watson, Rohit Gaurav, Lisa Swift, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|June 1, 2007
Sirolimus-induced pneumonitis following liver transplantationRebecca J Roberts, Antonia C Wells, Esther Unitt, et al.
The British Journal of Surgery|April 20, 2023
Outcomes of livers from donation after circulatory death donors with extended agonal phase and the adjunct of normothermic regional perfusionJames A Richards, Rohit Gaurav, Sara S Upponi, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|November 30, 2007
A randomized controlled trial of late conversion from calcineurin inhibitor (CNI)-based to sirolimus-based immunosuppression in liver transplant recipients with impaired renal functionChristopher J E Watson, Alexander E S Gimson, Graeme J Alexander, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Hospital Medicine (London, England : 1998)|November 5, 2004
Fatty liverMichael E D Allison
BMJ (Clinical Research Ed.)|July 4, 2008
Fatal reactivation of hepatitis B after chemotherapy for lymphomaRichard Dillon, Gideon M Hirschfield, Michael E D Allison, et al.
Histopathology|January 31, 2016
Any value in a specialist review of liver biopsies? Conclusions of a 4-year reviewAnna L Paterson, Michael E D Allison, Rebecca Brais, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|May 22, 2025
Motivation, self-efficacy, and identity-double-edged swords for relapse prevention in patients with alcohol related cirrhosisChristopher Oldroyd, Tamar Avades, Graham P Martin, et al.
Addiction (Abingdon, England)|November 10, 2025
Zero tolerance for 0%? How should clinicians and other practitioners respond to the use of alcohol-free and low-alcohol products in higher risk groupsJohn Holmes, Christopher K Oldroyd, Colin Drummond, et al.
Cell Death and Differentiation|April 2, 2020
OTULIN protects the liver against cell death, inflammation, fibrosis, and cancerRune Busk Damgaard, Helen E Jolin, Michael E D Allison, et al.
Transplantation|February 27, 2024
Bile Chemistry During Ex Situ Normothermic Liver Perfusion Does Not Always Predict CholangiopathyChristopher J E Watson, Rohit Gaurav, Lisa Swift, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|June 1, 2007
Sirolimus-induced pneumonitis following liver transplantationRebecca J Roberts, Antonia C Wells, Esther Unitt, et al.
The British Journal of Surgery|April 20, 2023
Outcomes of livers from donation after circulatory death donors with extended agonal phase and the adjunct of normothermic regional perfusionJames A Richards, Rohit Gaurav, Sara S Upponi, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|November 30, 2007
A randomized controlled trial of late conversion from calcineurin inhibitor (CNI)-based to sirolimus-based immunosuppression in liver transplant recipients with impaired renal functionChristopher J E Watson, Alexander E S Gimson, Graeme J Alexander, et al.
Pageof 2